HK1044932A1 - Intermediates for the synthesis of benzimidazole compounds and process for the preparation thereof - Google Patents

Intermediates for the synthesis of benzimidazole compounds and process for the preparation thereof

Info

Publication number
HK1044932A1
HK1044932A1 HK02106304A HK02106304A HK1044932A1 HK 1044932 A1 HK1044932 A1 HK 1044932A1 HK 02106304 A HK02106304 A HK 02106304A HK 02106304 A HK02106304 A HK 02106304A HK 1044932 A1 HK1044932 A1 HK 1044932A1
Authority
HK
Hong Kong
Prior art keywords
compound
preparation
chem
formula
intermediates
Prior art date
Application number
HK02106304A
Other languages
English (en)
Inventor
Naoyuki Kishi
Yoshitaka Nakamura
Narumi Abe
Tzoyonori Takebayashi
Original Assignee
Sankyo Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo Co filed Critical Sankyo Co
Publication of HK1044932A1 publication Critical patent/HK1044932A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06—Esters of carbamic acids
    • C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/26—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atom of at least one of the carbamate groups bound to a carbon atom of a six-membered aromatic ring
    • C07C271/28—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atom of at least one of the carbamate groups bound to a carbon atom of a six-membered aromatic ring to a carbon atom of a non-condensed six-membered aromatic ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/34—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
HK02106304A 1999-06-28 2002-08-27 Intermediates for the synthesis of benzimidazole compounds and process for the preparation thereof HK1044932A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP18189899 1999-06-28
PCT/JP2000/004213 WO2001000570A1 (fr) 1999-06-28 2000-06-27 Intermediaires pour la synthese de composes de benzimidazole et procede de preparation

Publications (1)

Publication Number Publication Date
HK1044932A1 true HK1044932A1 (en) 2002-11-08

Family

ID=16108822

Family Applications (1)

Application Number Title Priority Date Filing Date
HK02106304A HK1044932A1 (en) 1999-06-28 2002-08-27 Intermediates for the synthesis of benzimidazole compounds and process for the preparation thereof

Country Status (19)

Country Link
US (2) US6525220B2 (de)
EP (2) EP1191019B1 (de)
KR (1) KR100731946B1 (de)
CN (2) CN1611489A (de)
AT (1) ATE336482T1 (de)
AU (1) AU5570000A (de)
CA (1) CA2377233C (de)
CZ (1) CZ20014412A3 (de)
DE (1) DE60030118T2 (de)
ES (1) ES2270843T3 (de)
HK (1) HK1044932A1 (de)
HU (1) HUP0201559A3 (de)
IL (2) IL146916A0 (de)
MX (1) MXPA02000069A (de)
NO (1) NO20016366L (de)
PL (1) PL352383A1 (de)
RU (1) RU2224742C2 (de)
TW (1) TWI262180B (de)
WO (1) WO2001000570A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6489346B1 (en) * 1996-01-04 2002-12-03 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
US5840737A (en) 1996-01-04 1998-11-24 The Curators Of The University Of Missouri Omeprazole solution and method for using same
KR101150739B1 (ko) * 2004-09-28 2012-06-08 상꾜 가부시키가이샤 6-치환-1-메틸-1-ｈ-벤즈이미다졸 유도체의 제조 방법 및 그 제조 중간체
TW200637856A (en) * 2005-01-24 2006-11-01 Sankyo Co Process for producing thiazolidinedion compound and intermediate thereof
CA2781800A1 (en) 2009-11-26 2011-06-03 Daiichi Sankyo Company, Limited Method for manufacturing a 6-substituted 1-methyl-1h-benzimidazole derivative and an intermediate of said method

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0745600A (ja) * 1993-01-20 1995-02-14 Hitachi Ltd 液中異物付着防止溶液とそれを用いたエッチング方法及び装置
US5652237A (en) * 1994-09-09 1997-07-29 Warner-Lambert Company 2-substituted-4H-3, 1-benzoxazin-4-ones and benzthiazin-4-ones as inhibitors of complement C1r protease for the treatment of inflammatory processes
IL118474A (en) 1995-06-01 2001-08-08 Sankyo Co Benzimideol derivatives and pharmaceutical preparations containing them
PL200859B1 (pl) * 1997-10-08 2009-02-27 Sankyo Co Podstawiony skondensowany związek heterocykliczny, kompozycja farmaceutyczna zawierająca podstawiony skondensowany związek heterocykliczny oraz zastosowanie podstawionego skondensowanego związku heterocyklicznego

Also Published As

Publication number Publication date
HUP0201559A2 (en) 2002-08-28
EP1191019A1 (de) 2002-03-27
NO20016366D0 (no) 2001-12-27
CA2377233C (en) 2009-03-10
CN1371360A (zh) 2002-09-25
HUP0201559A3 (en) 2004-03-01
EP1191019B1 (de) 2006-08-16
US20030008907A1 (en) 2003-01-09
RU2224742C2 (ru) 2004-02-27
CA2377233A1 (en) 2001-01-04
DE60030118T2 (de) 2007-03-15
DE60030118D1 (de) 2006-09-28
US6525220B2 (en) 2003-02-25
US6753347B2 (en) 2004-06-22
ES2270843T3 (es) 2007-04-16
CN1611489A (zh) 2005-05-04
KR20020087835A (ko) 2002-11-23
MXPA02000069A (es) 2002-07-02
WO2001000570A1 (fr) 2001-01-04
ATE336482T1 (de) 2006-09-15
NO20016366L (no) 2002-02-27
PL352383A1 (en) 2003-08-25
KR100731946B1 (ko) 2007-06-25
TWI262180B (en) 2006-09-21
US20030199580A1 (en) 2003-10-23
IL146916A0 (en) 2002-08-14
IL146916A (en) 2008-07-08
CN1249024C (zh) 2006-04-05
EP1191019A4 (de) 2004-06-02
AU5570000A (en) 2001-01-31
CZ20014412A3 (cs) 2002-04-17
EP1607385A1 (de) 2005-12-21

Similar Documents

Publication Publication Date Title
PT1004578E (pt) Derivados hidroxamida do acido 5-oxo-pirrolidino-2-carboxilico
MY121760A (en) Benzothiazin and benzoxazin derivatives;their preparation and uses
DE60012751D1 (de) Verwendung von ep4 rezeptorliganden zur behandlung von neuropathischen schmerz
AU6518998A (en) Morphinane derivatives and medicinal use thereof
ES8801915A1 (es) Un procedimiento para preparar derivados de piperidina.
AU7517400A (en) N-substituted 4-aminopteridines, synthesis and use thereof as pharmaceutical agent
WO2001090097A3 (en) Novel compounds having antiinflammatory activity: process for their preparation and pharmaceutical compositions containing them
MXPA01007940A (es) Derivados de azabicicloalcano y usos terapeuticos de los mismos.
HRP20000304B1 (en) Biphenylamidine derivatives
PT1026167E (pt) Derivados triciclicos de triazolbenzazepina processo para a sua preparacao e agentes anti-alergicos
EA200100090A3 (ru) Новые пиперидин-4-сульфонамидные производные, способ их получения и содержащие их фармацевтические композиции
GB9004301D0 (en) Indolebutyric acid derivatives and process for preparation thereof
DE60002949D1 (de) Verfahren zur Herstellung des Neuraminidase-Inhibitoren ro-64-0796
HK1044932A1 (en) Intermediates for the synthesis of benzimidazole compounds and process for the preparation thereof
AU6220300A (en) Benzofurylpiperazine serotonin agonists
ES2158425T3 (es) Procedimiento para la preparacion de derivados de pirimidina.
CA2336380A1 (en) Novel antihistaminic piperidine derivatives and intermediates for the preparation thereof
EP1319656A4 (de) Neues verfahren zur herstellung einer chinolon-carbonsäure
EP0860169A3 (de) Pyridazinon-Verbindungen enthaltenden Zusammensetzungen zur oralen Verabreichung
CA2245484A1 (en) Novel urea derivatives
WO2001083423A3 (en) 2,6-diamino-6-methyl-heptanoic acid and derivatives, process for the preparation thereof and use thereof
EP1005334A4 (de) Nervenschützende verbindungen und ihre verwendungen
MXPA04002784A (es) Sales farmaceuticamente aceptables de 20(s)-camptotecinas.
PL145043B1 (en) Method of obtaining concentrated derivatives of as-triazine
KR960031439A (ko) 치환 인돌 유도체

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20130627